Nootropics

Armodafinil

A prescription wakefulness medicine with evidence in diagnosed shift work disorder, not a substitute for sleep.

Controlled disorder-specific evidence

Also known as: Nuvigil

Armodafinil molecular structure — Structure reference · C15H15NO2S

Practical use

Reviewed practical notes

Keep the diagnosis attached: A night-work schedule alone does not reproduce trial eligibility.
Read the outcome accurately: Improved sleep latency does not mean sleepiness disappeared.
Use the full medication history: Contraception and other medicines belong in the prescribing review.

2009 shift work disorder trial

Current NUVIGIL prescribing information

Overview

Armodafinil is the R-enantiomer of modafinil. Its US label covers excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder in adults. These are specific treatment settings, not a general indication for working through the night.

Risks and limitations

Label warnings include serious rash, psychiatric symptoms, cardiovascular concerns and persistent sleepiness. Headache, nausea, dizziness and insomnia are common adverse reactions. Medicine interactions include reduced effectiveness of steroidal contraception.

How to read this

In sleep apnea, treatment of sleepiness does not correct airway obstruction. More alertness also does not guarantee safe driving. Ongoing symptoms and the underlying sleep condition remain relevant even when a medicine helps.

Research explained

Shift work disorder trial

Who was studied

254 night workers with at least three months of moderate or severe shift work disorder; randomized double-blind placebo comparison over 12 weeks.

What was found

Mean nighttime sleep latency increased from 2.3 to 5.3 minutes with armodafinil, versus 2.4 to 2.8 with placebo. Clinical improvement was reported in 79% versus 59%.

What it cannot establish

The trial studied a diagnosed disorder. Residual sleepiness remained, and comparison with placebo does not establish superiority over modafinil or benefit for healthy all-night work.

Read the original study

A longer time to fall asleep is a specific test result

The trial assessed sleep propensity under standardized conditions. Those minutes are not extra hours of safe work or a measure of sleep need. Memory and attention findings in the same population should retain that clinical context.

Supporting source

A related molecule still has its own label

Armodafinil and modafinil are closely related medicines, but a claim that one is the better choice requires an appropriate comparison. Chemical identity alone cannot establish better everyday outcomes.